Nationality: United States
Position: Chief, Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, NIAID/NIH
Research Fields: Antiviral therapy for RVI, Vaccination in Immunocompromised Hosts
Short description:
Dr. Michael Ison completed his medical school training at University of South Florida College of Medicine and obtained training in Internal Medicine at Oregon Health Sciences University in Portland, Oregon followed by Infectious Diseases at the University of Virginia. After spending 17 years as a Professor in the Divisions of Infectious Diseases and Organ Transplantation at Northwestern University Feinberg School of Medicine, he moved to become the Respiratory Disease Branch Chief within the Division of Microbiology and Infectious Diseases at NIAID/NIH.
During his fellowship, he was mentored by Drs. Frederick Hayden, Larisa Gubareva, and Tom Brachiale. His research focused on the immunopathogenesis of influenza and its treatment in immunosuppressed and hospitalized patients. He is currently also the Chair of the Antiviral Group of the International Society of Influenza and Other Respiratory Viruses. He has led a number of clinical studies focused on influenza, RSV and COVID-19 antivirals and vaccines at Northwestern University Feinberg School of Medicine, including the development of a serial sampling biobank, a convalescent plasma bank and a clinical datamart.
